Samsung Biologics Achieves EcoVadis Platinum Rating for Sustainability Excellence

Samsung Biologics Attains EcoVadis Platinum Sustainability Rating

On January 28, 2026, Samsung Biologics, a prominent contract development and manufacturing organization (CDMO) based in Incheon, South Korea, proudly announced that it has secured the prestigious EcoVadis Platinum Sustainability Rating. This rating signifies the pinnacle of corporate sustainability recognition and positions Samsung Biologics among the elite one percent of companies evaluated globally by EcoVadis, which assesses corporate social responsibility relying on comprehensive metrics.

EcoVadis stands as a vital platform that evaluates businesses across four key categories: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Samsung Biologics has demonstrated its unwavering commitment to sustainability management and practices, earning accolades for its continuous advancements in these areas.

Before receiving the Platinum rating, Samsung Biologics was awarded the Gold Sustainability Rating in 2024, indicating a consistent trajectory of improvement followed by a rigorous evaluation period. This latest achievement underscores the company's dedication to implementing effective sustainability practices across its operational and supply chain ecosystems.

John Rim, President and CEO of Samsung Biologics, expressed his pride in the company’s accomplishment, stating, "This recognition reflects the steady progress we have made in advancing sustainability practices across our operations and supply chain. As ESG expectations continue to evolve globally, we remain focused on our commitment to responsible business practices that support long-term partnerships and contribute to a more sustainable healthcare ecosystem."

In recent years, Samsung Biologics has significantly expanded its sustainability initiatives. Notable among these efforts is the increased utilization of renewable energy sources across its manufacturing operations, a crucial step in curbing carbon emissions and fostering a greener environment. Additionally, the company has reinforced its ethical and compliance frameworks, ensuring adherence to high standards of corporate governance and sustainability.

Noteworthy is Samsung Biologics’ exemplary performance on the Carbon Disclosure Project’s (CDP) Water Security assessment where it achieved an 'A' rating in December 2025. This acknowledgment showcases the firm’s commitment to responsible water management and preserving vital natural resources.

As a proactive participant in the Sustainable Markets Initiative Health Systems Task Force, Samsung Biologics actively engages with global suppliers to promote decarbonization efforts and to develop resilient value chains. These strategic collaborations are aimed at emphasizing sustainability across the entire lifecycle of its products.

Samsung Biologics offers comprehensive contract development and manufacturing services that span from late-stage discovery through to commercial manufacturing. With a combined production capacity of 785,000 liters at its Bio Campus facilities and an additional 60,000 liters planned through a facility acquisition in Rockville, Maryland, USA, the company boasts significant capabilities in various biomanufacturing modalities, including multispecific antibodies and mRNA therapeutics.

To standardize its operations across different plants, Samsung Biologics has implemented its proprietary ExellenS™ framework. This initiative emphasizes consistent manufacturing processes, advanced digitalization, and streamlined designs, thereby ensuring both operational efficiency and exceptional quality.

With a solid global presence in manufacturing and commercial operations across Korea, the U.S., and Japan, Samsung Biologics is committed to delivering safe, high-quality biomedicines promptly. The company emphasizes a forward-thinking approach that aligns its operational priorities with sustainable business decisions to contribute positively to society and global health.

For further insights into Samsung Biologics' sustainability efforts and innovations, please visit their official website: samsungbiologics.com.